The antinuclear antibody (ANA) test has high sensitivity in diagnosing and classifying
systemic lupus erythematosus (SLE). Objectives To describe the immunological pattern of …

Background: Systemic Lupus Erythematosus (SLE), a systemic autoimmune disease, is
diagnosed by correlating clinical features with a positive Antinuclear Antibody (ANA) test …

The aim of this study is to evaluate the relationship between antinuclear antibody (ANA) titer
and specificity, as well as the relationship between the number of positive-autoantibodies …

Objective The expression of antinuclear antibodies (ANA) is considered almost constant in
systemic lupus erythematosus (SLE), although recent experience has suggested that many …

Objective To evaluate antinuclear antibody (ANA) tests in established cases of systemic
lupus ery-thematosus (SLE) and rheumatoid arthritis (RA) by indirect immunofluorescence …

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease with highly
variable clinical and immunological manifestations. In the classification of patients with this …

Aims of the study: To evaluate the advantages and reliability of screening for antinuclear
antibodies (ANA) by enzyme immunoassay (ELISA). Methodology: Sera from 96 patients …

The detection of antinuclear antibodies (ANAs) in serum facilitates the diagnosis of patients
with systemic lupus erythematosus (SLE) and related autoimmune diseases. Conversely …

Objectives. To evaluate and compare the performances of three enzyme-immunoassays
(EIAs) and a double radial immunodiffusion (DRID) test in addition to immunofluorescence …

Systemic lupus erythematosus (SLE) is an autoimmune inflammatory condition that may
involve multiple organ systems. Although the antinuclear antibody (ANA) test is positive in …